Low Liver Enzymes in Routine Blood Tests May Signal Higher Risk for Early-Onset Colorectal Cancer
New analysis from Epic Research suggests that adults under 45 with lower levels of liver enzymes AST and ALT may have a higher likelihood of developing early-onset colorectal cancer. The study found that low enzyme levels were associated with a 65-68% increased risk, while higher levels correlated with lower risk. Experts caution that these findings are observational and do not change current screening guidelines, which recommend starting at age 45 for average-risk individuals. The results highlight a potential link between metabolic health and cancer risk but require further validation before clinical application.
